Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Gemilukast (ONO-6950) is an orally active and potent dual inhibitor of cysteinyl leukotriene 1 and 2 receptors (CysLT1 and CysLT2), inhibits LTC 4-induced bronchoconstriction, and is inhibitory to human CysLT1 and CysLT2, and may be used in the treatment of asthma.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
5 mg | 在庫あり | ¥ 15,000 | |||
10 mg | 在庫あり | ¥ 22,500 | |||
25 mg | 在庫あり | ¥ 41,500 | |||
50 mg | 在庫あり | ¥ 61,000 | |||
100 mg | 在庫あり | ¥ 90,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 44,500 |
ターゲット&IC50 | CysLT2:25 nM (Human), CysLT1:1.7 nM (Human) |
別名 | ONO-6950 |
分子量 | 601.68 |
分子式 | C36H37F2NO5 |
CAS No. | 1232861-58-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 100 mg/mL (166.20 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Gemilukast 1232861-58-3 Others ONO 6950 ONO-6950 ONO6950 Inhibitor inhibitor inhibit